US stock · data to 2026-10-20
Pfizer (PFE)
Pfizer: $30.04 on 2026-10-20. +8.2% a year since 1980, worst fall -77%. Year-by-year returns, risk profile and what followed its price patterns in the past.
Open the interactive chart and full historyKey numbers
| Last close | $30.04 |
| Return a year since 1980 | +8.2% |
| All-time high | $61.25 (2021-12-16) |
| Below its high | -51.0% |
| Worst fall | -77% (2009-03-02) |
| Yearly volatility | 27% |
| Beta vs its index | 0.81 |
| Risk / reward vs its market | Low risk · Low reward |
Returns by year
| Year | Return |
|---|---|
| 2026 | +20.6% |
| 2025 | -6.1% |
| 2024 | -7.8% |
| 2023 | -43.8% |
| 2022 | -13.2% |
| 2021 | +60.4% |
| 2020 | -1.0% |
| 2019 | -10.2% |
| 2018 | +20.5% |
| 2017 | +11.5% |
| 2016 | +0.6% |
| 2015 | +3.6% |
What followed its price patterns in the past
How often PFE was higher 40 trading days after each pattern, next to an ordinary day. History for learning, not a forecast.
| Pattern | Past cases | Higher after 40 days | On an ordinary day | Median move |
|---|---|---|---|---|
| Down streak | 145 | 60% | 56% | +1.7% |
| Big up day | 136 | 59% | 56% | +2.2% |
| Up streak | 127 | 55% | 56% | +0.7% |
| RSI rises above 70 | 122 | 54% | 56% | +1.1% |
| Falls below 200-day avg | 118 | 57% | 56% | +2.1% |
| New 52-week high | 117 | 56% | 56% | +1.3% |
| Crosses above 200-day avg | 113 | 62% | 56% | +1.7% |
| Big down day | 94 | 48% | 56% | -0.3% |
| RSI drops below 30 | 84 | 67% | 56% | +3.5% |
| Squeeze breakout up | 72 | 60% | 56% | +3.0% |
| Volume spike on a down day | 69 | 51% | 56% | +0.9% |
| Squeeze breakdown | 67 | 43% | 56% | -1.9% |
ZOSH shows history and calculations for learning. It is not investment advice and does not tell anyone to buy or sell. Data: Yahoo Finance, AMFI, NSE and official sources; it can be late or wrong, so check before acting.